X-ray contrast media compositions and methods of using the same

1. A method of treating a nasal allergic condition in a mammal in need thereof, comprising administering to a nasal tissue of a mammal suffering from a nasal allergic condition a composition comprising an X-ray contrast media in an amount sufficient to treat said nasal allergic condition, wherein

a) said X-ray contrast media comprises a triiodinated, benzene moiety;

b) said X-ray contrast media is a non-ionic monomer, non-ionic dimer, ionic monomer or ionic dimer; and wherein

c) the composition comprises zinc in an amount from 0.1×10 −3 mg to 4×10 −3 mg.

2. The method of claim 1 , wherein the nasal allergic condition is allergic rhinitis.

3. The method of claim 1 , wherein the X-ray contrast media comprises completely or partially substituted benzene moieties.

4. The method of claim 1 , wherein the X-ray contrast media is selected from the group consisting of iopamidol, ioversol, iopromide, iohexol, iothalamate, iothalamic acid, diatrizoate, ioxaglate, ioxaglic acid, iodipamide, iodixanol, iopanoic acid, sodium tyropanoate, iotrolan, acetrizoate sodium, bunamidiodyl sodium, diatrizoate sodium, iobenzamic acid, iocarmic acid, iocetamic acid, iodamide, iodophthalein sodium, ioglycamic acid, iomeglamic acid, iopental, iophenoxic acid, ipronic acid, ioxilan, ipodate, meglumine acetrizoate, meglumine diatrizoate, metrizamide, metrizoic acid, phenobutiodil, phentetiothalein sodium, tyropanoate sodium, and combinations thereof.

5. The method of claim 4 , wherein the X-ray contrast media is iopamidol, ioversol, iopromide, iohexol, iothalamate, iothalamic acid, diatrizoate, ioxaglate or combinations thereof.

6. The method of claim 5 , wherein the X-ray contrast media is ioxaglate.

7. The method of claim 1 , wherein the X-ray contrast media is administered in a concentration of 150 mg l/mL to 350 mg l/mL.